Ppd Development Lp Federal Spending Profile
Ppd Development Lp is a mid-sized federal recipient, with $139.7M in total federal obligations spread across 25 awards reported on USAspending.gov. That places Ppd Development Lp #553 among federal contractors ranked by total obligations.
Every one of Ppd Development Lp's 25 federal awards is a procurement contract rather than a grant — the company sells goods or services to the government rather than receiving grant funding.
Ppd Development Lp's federal business is heavily concentrated in one customer: Department of Health and Human Services accounts for roughly 100% of its top-agency obligations, with Department of Defense a distant second. Across the full record the company works with 2 agencies, but a single relationship dominates the dollars.
What the federal government buys from Ppd Development Lp is led by Research & Development ($474.7M), followed by Other Services ($457.3M); together these categories describe the goods and services the company is paid to deliver.
Its largest single recent award is a $329.8M contract from the Department of Health and Human Services, described in the federal record as "Igf::Ot::Igf Niaid Hiv And Other Infectious Diseases Clinical Research Support Services (Crss)."
Track Ppd Development Lp
Subscribe for TaxDollarData updates by email. No spam, unsubscribe anytime.
Spending by Agency
Recent Awards
| Description | Agency | Start Date | Amount |
|---|---|---|---|
| IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | Department of Health and Human Services | Aug 14, 2017 | $329.8M |
| IGF::OT::IGF NIAID CLINICAL SITE MONITORING | Department of Health and Human Services | Jan 31, 2017 | $135.1M |
| ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE DEVELOPMENT, ASSESSING IMPACT OF VARIANTS ON VACCINE IMMUNOGENICITY, AND ANALYZ | Department of Health and Human Services | Sep 29, 2023 | $126.5M |
| BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS. | Department of Health and Human Services | Dec 15, 2023 | $117.4M |
| NIAID CLINICAL SITE MONITORING (NCSM) | Department of Health and Human Services | Feb 1, 2024 | $73.2M |
| "COVID 19"COMPLETION OF ACTIV 2 STUDY | Department of Health and Human Services | Nov 6, 2022 | $64.0M |
| COVID 19. THIS TASK ORDER IS TO PROVIDE COMPREHENSIVE/FULL CLINICAL TRIAL MANAGEMENT SUPPORT SERVICES TO THE ONGOING ACTIV-2 CLINICAL TRIAL. THE CONTRACTOR SHALL COMPLY WITH REGULATORY GUIDANCE, MAINTAIN DATA INTEGRITY, PROVIDE CRITICAL DATA RELATED | Department of Health and Human Services | May 6, 2022 | $34.6M |
| NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | Department of Health and Human Services | Jun 30, 2022 | $28.6M |
| TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER | Department of Health and Human Services | Dec 16, 2011 | $27.2M |
| R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) | Department of Health and Human Services | Nov 1, 2011 | $22.0M |
| REGULATORY MANAGEMENT CENTER (RMC) | Department of Health and Human Services | Nov 1, 2021 | $17.4M |
| COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | Department of Health and Human Services | Aug 15, 2024 | $17.2M |
| TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIX | Department of Health and Human Services | Apr 15, 2019 | $5.8M |
| EPCTU | Department of Health and Human Services | Jun 29, 2023 | $2.8M |
| FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY | Department of Health and Human Services | Jul 8, 2016 | $2.8M |
| TBTC MONITORING | Department of Health and Human Services | Jun 10, 2021 | $2.1M |
| BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION | Department of Health and Human Services | Jul 1, 2019 | $1.8M |
| IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER NO. 2 - PETRUKIN | Department of Health and Human Services | Jun 1, 2018 | $1.7M |
| ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES | Department of Health and Human Services | Nov 16, 2020 | $1.4M |
| FDA REGULATORY COMPLIANCE TRAINING | Department of Defense | Oct 25, 2017 | $1.3M |
All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.
Ppd Development Lp Federal Contracts FAQ
Ppd Development Lp has received $139,709,313 in total federal obligations across 25 awards and 25 contracts.
Ppd Development Lp works with 2 federal agencies, including Department of Health and Human Services, Department of Defense. The largest agency relationships are based on total dollar obligations.
Ppd Development Lp has received federal awards in multiple states.
Ppd Development Lp is ranked #553 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.
Explore Other Federal Contractors
Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.